Cancer/Tumor Profiling Market - Forecast To 2025
Healthcare - Medical Devices
Report Code: MD 4803
Published:
Jul 2020
Like what you are reading?
Ask a Question
Select Use Case :
See what others are asking
-
MNM delivered a custom study on the laryngoscope blades market for North America.
Connected Markets: 16
-
Delivered a global analysis of contrast injector market with a specific focus on China
Connected Markets: 38
-
Helped a global leader in the analytical laboratory solutions market to identify new revenue sources in biomarker industry valued at USD 55 million by 2025
Connected Markets: 8
-
Helped a top global leader to identify approximately USD 1 billion revenue potential by tapping into the Optical Coherence Tomography (OCT) market
Connected Markets: 29
-
Helped a leading global innovative molecular diagnostics company in molecular testing having a unique proprietary platform using real-time PCR-based molecular testing system to identify approximately USD 650 million revenue potential by tapping into NGS Market for Cancer/Tumor Profiling in US, Europe, and RoW
Connected Markets: 8
-
Helped a leading medical device manufacturer to tap into USD 6 billion peritoneal dialysis market with an expected revenue gain of USD 25 million during next 5 years
Connected Markets: 12
-
Helped a global management consulting services and solutions provider in delivering the market size of esoteric testing services across Japan and Singapore.
Connected Markets: 23
-
Helped the client in devising strategic plans to increase volume sales of target fetal/neonatal care products in major geographies so as to result in an additional revenue opportunity of USD 110 million by 2023
Connected Markets: 35
-
Market Assessment - NGS services market in North America
Connected Markets: 50
-
Market Assessment - HIV Drug Resistance Testing Kits in North America
Connected Markets: 50
-
End-user analysis - Library Prep Market in USA
Connected Markets: 50
-
Market Assessment - NGS Installations market
Connected Markets: 50
-
Table 1 market Drivers: Impact analysis
-
Table 2 market Restraints: Impact analysis
-
Table 3 market opportunities: Impact analysis
-
Table 4 market Challenges: Impact analysis
-
Table 5 Cancer/tumor profiling Market, By technology, 2017–2019 (USD Million)
-
Table 6 Cancer/tumor profiling Market, By technology, 2020–2025 (USD Million)
-
Table 7 cancer/tumor profiling Market for Immunoassays, By country/Region, 2017–2019 (USD MIllion)
-
Table 8 cancer/tumor profiling Market for Immunoassays, By country/region, 2020–2025 (USD MIllion)
-
Table 9 cancer/tumor profiling Market for Next generation sequencing, By country/Region, 2017–2019 (USD MIllion)
-
Table 10 cancer/tumor profiling Market for Next generation sequencing, By country/Region, 2020–2025 (USD MIllion)
-
Table 11 cancer/tumor profiling Market for Polymerase chain reaction, By country/Region, 2017–2019 (USD MIllion)
-
Table 12 cancer/tumor profiling Market for Polymerase chain reaction, By country/Region, 2020–2025 (USD MIllion)
-
Table 13 cancer/tumor profiling Market for In situ hybridization, By country/Region, 2017–2019 (USD MIllion)
-
Table 14 cancer/tumor profiling Market for In situ hybridization, By country/Region, 2020–2025 (USD MIllion)
-
Table 15 cancer/tumor profiling Market for microarrays, By country/Region, 2017–2019 (USD MIllion)
-
Table 16 cancer/tumor profiling Market for microarrays, By country/Region, 2020–2025 (USD MIllion)
-
Table 17 cancer/tumor profiling Market for Mass spectrometry, By country/Region, 2017–2019 (USD MIllion)
-
Table 18 cancer/tumor profiling Market for Mass spectrometry, By country/Region, 2020–2025 (USD MIllion)
-
Table 19 cancer/tumor profiling Market for other technologies, By country/Region, 2017–2019 (USD MIllion)
-
Table 20 cancer/tumor profiling Market for other technologies, By country/Region, 2020–2025 (USD MIllion)
-
Table 21 Cancer/tumor profiling Market, By cancer type, 2017–2019 (USD Million)
-
Table 22 Cancer/tumor profiling Market, By cancer type, 2020–2025 (USD Million)
-
Table 23 cancer/tumor profiling Market for breast cancer, By country/Region, 2017–2019 (USD MIllion)
-
Table 24 cancer/tumor profiling Market for breast cancer, By country/Region, 2020–2025 (USD MIllion)
-
Table 25 cancer/tumor profiling Market for lung cancer, By country/Region, 2017–2019 (USD MIllion)
-
Table 26 cancer/tumor profiling Market for lung cancer, By country/Region, 2020–2025 (USD MIllion)
-
Table 27 cancer/tumor profiling Market for colorectal cancer, By country/Region, 2017–2019 (USD MIllion)
-
Table 28 cancer/tumor profiling Market for colorectal cancer, By country/Region, 2020–2025 (USD MIllion)
-
Table 29 cancer/tumor profiling Market for prostate cancer, By country/Region, 2017–2019 (USD MIllion)
-
Table 30 cancer/tumor profiling Market for prostate cancer, By country/Region, 2020–2025 (USD MIllion)
-
Table 31 cancer/tumor profiling Market for melanoma, By country/Region, 2017–2019 (USD MIllion)
-
Table 32 cancer/tumor profiling Market for melanoma, By country/Region, 2020–2025 (USD MIllion)
-
Table 33 cancer/tumor profiling Market for other cancers, By country/Region, 2017–2019 (USD MIllion)
-
Table 34 cancer/tumor profiling Market for other cancers, By country/Region, 2020–2025 (USD MIllion)
-
Table 35 Cancer/tumor profiling Market, By biomarker type, 2017–2019 (USD Million)
-
Table 36 Cancer/tumor profiling Market, By biomarker type, 2020–2025 (USD Million)
-
Table 37 cancer/tumor profiling Market for genetic biomarkers, By country/Region, 2017–2019 (USD MIllion)
-
Table 38 cancer/tumor profiling Market for genetic biomarkers, By country/Region, 2020-2025 (USD MIllion)
-
Table 39 cancer/tumor profiling Market for protein biomarkers, By country/Region, 2017–2019 (USD MIllion)
-
Table 40 cancer/tumor profiling Market for protein biomarkers, By country/Region, 2020–2025 (USD MIllion)
-
Table 41 cancer/tumor profiling Market for other biomarkers, By country/Region, 2017–2019 (USD MIllion)
-
Table 42 cancer/tumor profiling Market for other biomarkers, By country/Region, 2020–2025 (USD MIllion)
-
Table 43 Cancer/tumor profiling Market, By application, 2017–2019 (USD Million)
-
Table 44 Cancer/tumor profiling Market, By application, 2020–2025 (USD Million)
-
Table 45 cancer/tumor profiling Market for research applications, By type, 2017–2019 (USD MIllion)
-
Table 46 cancer/tumor profiling Market for research applications, By type, 2020–2025 (USD MIllion)
-
Table 47 cancer/tumor profiling Market for biomarker discovery, By country/Region, 2017–2019 (USD MIllion)
-
Table 48 cancer/tumor profiling Market for biomarker discovery, By country/Region, 2020–2025 (USD MIllion)
-
Table 49 cancer/tumor profiling Market for personalized medicine, By country/Region, 2017–2019 (USD MIllion)
-
Table 50 cancer/tumor profiling Market for personalized medicine, By country/Region, 2020–2025 (USD MIllion)
-
Table 51 cancer/tumor profiling Market for clinical applications, By type, 2017–2019 (USD MIllion)
-
Table 52 cancer/tumor profiling Market for clinical applications, By type, 2020–2025 (USD MIllion)
-
Table 53 cancer/tumor profiling Market for diagnostics, By country/Region, 2017–2019 (USD MIllion)
-
Table 54 cancer/tumor profiling Market for diagnostics, By country/Region, 2020–2025 (USD MIllion)
-
Table 55 cancer/tumor profiling Market for prognostics, By country/Region, 2017–2019 (USD MIllion)
-
Table 56 cancer/tumor profiling Market for prognostics, By country/Region, 2020–2025 (USD MIllion)
-
Table 57 cancer/tumor profiling Market for monitoring & treatment, By country/Region, 2017–2019 (USD MIllion)
-
Table 58 cancer/tumor profiling Market for monitoring & treatment, By country/Region, 2020–2025 (USD MIllion)
-
Table 59 cancer/tumor profiling Market for screening, By country/Region, 2017–2019 (USD MIllion)
-
Table 60 cancer/tumor profiling Market for screening, By country/Region, 2020–2025 (USD MIllion)
-
Table 61 cancer/tumor profiling market, By Region, 2017–2019 (USD Million)
-
Table 62 cancer/tumor profiling market, By Region, 2020–2025 (USD Million)
-
Table 63 North America: cancer/tumor profiling MARKET, BY country, 2017–2019 (USD MILLION)
-
Table 64 North America: cancer/tumor profiling MARKET, BY country, 2020–2025 (USD MILLION)
-
Table 65 North America: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 66 North America: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 67 North America: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 68 North America: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 69 North America: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 70 North America: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 71 North America: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 72 North America: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 73 North America: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 74 North America: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 75 US: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 76 US: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 77 US: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 78 US: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 79 US: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 80 US: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 81 US: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 82 US: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 83 US: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 84 US: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 85 CANADA: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 86 CANADA: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 87 CANADA: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 88 canada: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 89 CANADA: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 90 CANADA: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 91 CANADA: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 92 CANADA: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 93 CANADA: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 94 CANADA: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 95 EUROPE: cancer/tumor profiling MARKET, BY country, 2017–2019 (USD MILLION)
-
Table 96 EUROPE: cancer/tumor profiling MARKET, BY country, 2020–2025 (USD MILLION)
-
Table 97 EUROPE: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 98 EUROPE: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 99 EUROPE: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 100 EUROPE: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 101 EUROPE: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 102 EUROPE: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 103 EUROPE: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 104 EUROPE: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 105 EUROPE: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 106 EUROPE: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 107 GERMANY: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 108 germany: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 109 germany: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 110 germany: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 111 germany: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 112 germany: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 113 germany: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 114 germany: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 115 germany: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 116 germany: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 117 UK: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 118 uk: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 119 uk: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 120 uk: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 121 uk: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 122 uk: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 123 uk: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 124 uk: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 125 uk: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 126 uk: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 127 FRANCE: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 128 FRANCE: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 129 FRANCE: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 130 FRANCE: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 131 FRANCE: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 132 FRANCE: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 133 FRANCE: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 134 FRANCE: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 135 FRANCE: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 136 FRANCE: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 137 italy: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 138 italy: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 139 italy: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 140 italy: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 141 italy: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 142 italy: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 143 italy: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 144 italy: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 145 italy: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 146 italy: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 147 SPAIN: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 148 SPAIN: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 149 SPAIN: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 150 SPAIN: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 151 SPAIN: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 152 SPAIN: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 153 SPAIN: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 154 SPAIN: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 155 SPAIN: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 156 SPAIN: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 157 rest of europe: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 158 rest of europe: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 159 rest of europe: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 160 rest of europe: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 161 rest of europe: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 162 rest of europe: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 163 rest of europe: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 164 rest of europe: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 165 rest of europe: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 166 rest of europe: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 167 ASIA PACIFIC: cancer/tumor profiling MARKET, BY country, 2017–2019 (USD MILLION)
-
Table 168 ASIA PACIFIC: cancer/tumor profiling MARKET, BY country, 2020–2025 (USD MILLION)
-
Table 169 ASIA PACIFIC: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 170 ASIA PACIFIC: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 171 ASIA PACIFIC: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 172 ASIA PACIFIC: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 173 ASIA PACIFIC: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 174 ASIA PACIFIC: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 175 ASIA PACIFIC: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 176 ASIA PACIFIC: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 177 ASIA PACIFIC: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 178 ASIA PACIFIC: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 179 JAPAN: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 180 JAPAN: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 181 JAPAN: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 182 JAPAN: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 183 JAPAN: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 184 JAPAN: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 185 JAPAN: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 186 JAPAN: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 187 JAPAN: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 188 JAPAN: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 189 cHINA: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 190 cHINA: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 191 cHINA: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 192 cHINA: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 193 cHINA: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 194 cHINA: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 195 cHINA: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 196 cHINA: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 197 cHINA: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 198 cHINA: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 199 INDIA: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 200 INDIA: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 201 INDIA: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 202 INDIA: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 203 INDIA: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 204 INDIA: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 205 INDIA: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 206 INDIA: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 207 INDIA: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 208 INDIA: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 209 REST OF ASIA PACIFIC: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 210 REST OF ASIA PACIFIC: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 211 REST OF ASIA PACIFIC: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 212 REST OF ASIA PACIFIC: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 213 REST OF ASIA PACIFIC: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 214 REST OF ASIA PACIFIC: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 215 REST OF ASIA PACIFIC: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 216 REST OF ASIA PACIFIC: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 217 REST OF ASIA PACIFIC: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 218 REST OF ASIA PACIFIC: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 219 LATIN AMERICA: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 220 LATIN AMERICA: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 221 LATIN AMERICA: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 222 LATIN AMERICA: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 223 LATIN AMERICA: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 224 LATIN AMERICA: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 225 LATIN AMERICA: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 226 LATIN AMERICA: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 227 LATIN AMERICA: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 228 LATIN AMERICA: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 229 MIDDLE EAST: cancer/tumor profiling MARKET, BY Technology, 2017–2019 (USD MILLION)
-
Table 230 MIDDLE EAST: cancer/tumor profiling MARKET, BY Technology, 2020–2025 (USD MILLION)
-
Table 231 MIDDLE EAST: cancer/tumor profiling MARKET, BY cancer type, 2017–2019 (USD MILLION)
-
Table 232 MIDDLE EAST: cancer/tumor profiling MARKET, BY cancer type, 2020–2025 (USD MILLION)
-
Table 233 MIDDLE EAST: cancer/tumor profiling MARKET, BY biomarker type, 2017–2019 (USD MILLION)
-
Table 234 MIDDLE EAST: cancer/tumor profiling MARKET, BY biomarker type, 2020–2025 (USD MILLION)
-
Table 235 MIDDLE EAST: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 236 MIDDLE EAST: CANCER/TUMOR PROFILING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 237 MIDDLE EAST: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2019 (USD MILLION)
-
Table 238 MIDDLE EAST: CANCER/TUMOR PROFILING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2025 (USD MILLION)
-
Table 239 product Launches, 2016–2020
-
Table 240 Expansions, 2016–2020
-
Table 241 Acquisitions, 2016–2020
-
Table 242 Other strategies, 2016–2020
-
Figure 1 cancer/tumor Profiling MARKET
-
Figure 2 Research design
-
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
-
Figure 4 Segmental share analysis illustration
-
Figure 5 Top-down approach
-
Figure 6 data triangulation methodology
-
Figure 7 Cancer/tumor profiling market, by technology, 2020 vs. 2025 (USD Million)
-
Figure 8 Cancer/tumor profiling market, by cancer type, 2020 vs. 2025 (USD Million)
-
Figure 9 Cancer/tumor profiling market, by biomarker type, 2020 vs. 2025 (USD Million)
-
Figure 10 Cancer/tumor profiling market, by Application, 2020 vs. 2025 (USD Million)
-
Figure 11 Geographical snapshot of the Cancer/tumor profiling market
-
Figure 12 Increasing DEMAND FOR PERSONALIZED MEDICINE to drive market growth
-
Figure 13 china to register the Fastest growth in the cancer/tumor profiling market during the forecast period
-
Figure 14 apac to witness the Fastest growth during the forecast period (2020–2025)
-
Figure 15 Developing markets TO REGISTER a higher GROWTH rate between 2020 & 2025
-
Figure 16 cancer/tumor profiling market: Drivers, restraints, Opportunities, and Challenges
-
Figure 17 Global cancer incidence, 2008–2030
-
Figure 18 Launch of Personalized medicine products, 2008–2016
-
Figure 19 increasing use of integrated omics data and growing focus on liquid biopsy tests are key market trends
-
Figure 20 Impact of COVID-19 on the Cancer/tumor profiling market
-
Figure 21 Immunoassays to dominate the cancer/tumor profiling market during the forecast period
-
Figure 22 Breast Cancer segment to dominate the cancer/tumor profiling market during the forecast period
-
Figure 23 Global Lung cancer incidence, 2012-2030
-
Figure 24 Colorectal cancer incidence rate, key countries (2018)
-
Figure 25 Genetic Biomarkers to dominate the cancer/tumor profiling market during the forecast period
-
Figure 26 Research applications to dominate the cancer/tumor profiling market during the forecast period
-
Figure 27 cancer/tumor profiling Market: geographic snapshot
-
Figure 28 North America: cancer/tumor profiling Market Snapshot
-
Figure 29 Europe: cancer/tumor profiling Market Snapshot
-
Figure 30 Asia pacific: cancer/tumor profiling Market Snapshot
-
Figure 31 Collaborations, Partnerships, and Agreements—key growth strategy adopted by MARKET players from 2016 to April 2020
-
Figure 32 Cancer/tumor profiling market: Competitive Leadership Mapping (2018)
-
Figure 33 Illumina, inc.: Company Snapshot (2019)
-
Figure 34 Qiagen N.V.: Company Snapshot (2019)
-
Figure 35 Neogenomics, inc.: Company Snapshot (2019)
-
Figure 36 Sysmex Corporation: Company Snapshot (2019)
-
Figure 37 HTG Molecular Diagnostics, Inc.: Company Snapshot (2019)
-
Figure 38 Nanostring Technologies, Inc.: Company snapshot (2019)
-
Figure 39 Guardant Health, Inc.: company snapshot (2019)
-
Figure 40 F. Hoffmann-La Roche LTD: company snapshot (2019)
-
Figure 41 GenScript: Company Snapshot (2019)
Report Title | Report Title | Domain | Sub Domain | Market Size | CAGR | Publish Date | Publish Date |
---|